New molecular entities/new biologics - Boniva - Ibandronate - Roche/Glaxosmithkline - Treatment and prevention of osteoporosis

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2003年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [41] NEW FORMULATION WITH POTENTIAL FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND OSTEOARTHRITIS
    Torrent, A.
    Montell, E.
    Verges, J.
    Ruhi, R.
    Dalmau, P.
    Carceller, M.
    Blanco, A.
    Terencio, M.
    Ferrandiz, M.
    Alcaraz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 304 - 305
  • [42] NEW FORMULATION WITH POTENTIAL FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND OSTEOARTHRITIS
    Torrent, A.
    Montell, E.
    Verges, J.
    Ruhi, R.
    Dalmau, P.
    Carceller, M.
    Blanco, A.
    Terencio, M.
    Ferrandiz, M.
    Alcaraz, M.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 : S216 - S216
  • [43] Prevention and treatment of osteoporosis - Clinical guidelines and new evidence
    Compston, J
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 2000, 34 (06): : 518 - 521
  • [44] Trends in the Safety of New Molecular Entities and Therapeutic Biologics Approved by the FDA (1980-2014)
    Seoane-Vazquez, Enrique
    Rodriguez-Monguio, Rosa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 477 - 478
  • [45] New molecular entities - Zyvox
    不详
    FORMULARY, 2000, 35 (06) : 474 - 474
  • [46] New molecular entities - Evoxac
    不详
    FORMULARY, 2000, 35 (03) : 205 - 205
  • [47] New Drugs and New Molecular Entities in Dermatology
    Eaglstein, William H.
    Corcoran, Gavin
    ARCHIVES OF DERMATOLOGY, 2011, 147 (05) : 568 - 572
  • [48] New molecular entities - Campath
    不详
    FORMULARY, 2001, 36 (06) : 402 - +
  • [49] New molecular entities - Axert
    不详
    FORMULARY, 2001, 36 (06) : 402 - 402
  • [50] The outlook for new molecular entities
    Pharm. Technol., 2006, 10 (64-70):
12345